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Available online 12 September 2012Abstract Most work on embryonic stem cell differentiation uses mammalian cells derived from the blastocyst stage and some
of the most widely used protocols to induce differentiation involve growing these cells in monolayer culture. Equivalent stem
cells can be obtained from embryos of non-mammalian vertebrates, but to date this has only been successful in birds. These
cells can contribute to all somatic lineages in chimaeras and can be induced to differentiate into a variety of cell types in vitro
via embryoid body formation. However to date there are no reliable methods for differentiating them into descendants from
each of the germ layers in monolayer culture, comparable to the protocols used in mammals. Here we describe three simple
and reproducible protocols for differentiation of chick embryonic stem cells into mesoderm (bone), endoderm and
neuroectoderm (neurons and glia) in monolayer culture. These methods open the way for more direct comparisons of the
properties of mammalian and avian embryonic stem cells that may highlight similarities and differences.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Embryonic stem cells were first derived frommouse embryos at
preimplantation stages (for review see Evans, 2011). Non-
mammalian equivalents took a long time to be derived. The
group of Rob Etches was the first to report that dissociated cells
from early chick blastoderms can be injected into an
X-irradiated host to generate high grade chimaeras. In these
chimaeras, the injected cells contribute to many if not all⁎ Corresponding author.
E-mail address: c.stern@ucl.ac.uk (C.D. Stern).
1873-5061/$ - see front matter © 2012 Elsevier B.V. All rights reserved.
http://dx.doi.org/10.1016/j.scr.2012.08.008somatic cell types (Carsience et al., 1993; Petitte et al., 1990).
A few years later, a collaborative study between Etches and
Bertrand Pain reported successful construction of similar
chimaeras after injecting chick blastodermal cells that had
been kept in culture (Pain et al., 1996). In this study, pluri-
potency of the blastodermal cells was also demonstrated by
showing that they can be differentiated into derivatives of all
three germ layers via embryoid body (EB) formation. Methods
for deriving these cells were subsequently refined further
(Etches et al., 1997; van de Lavoir and Mather-Love, 2006; van
de Lavoir et al., 2006) (see also review by Petitte et al., 2004).
To date, avian embryos remain the only non-mammalian system
from which pluripotent ES cell-like cultures can be established
from early embryonic cells, and maintained long-term.
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ation potential of mammalian ES cells (including mouse and
human) often uses cells grown inmonolayer culture, rather than
via EB formation. It is therefore desirable to devise methods for
achieving this for a non-mammalian system. Here we describe
simple and reliable protocols for generating cells from all three
germ layers from chick blastodermal cells: neural (ectoderm),
bone (mesoderm) and endodermal progenitors.
2. Materials and methods
2.1. Derivation of ES cells
Chick ES cells were derived as previously described (Petitte
and Yang, 1994; van de Lavoir and Mather-Love, 2006; Yang
and Petitte, 1994). Briefly, blastoderms were harvested from
stage X (Eyal-Giladi and Kochav, 1976) Brown Bovan Gold eggs
(Henry Stewart & Co.) and manually dissociated in tubes
containing PBS. Cells were centrifuged at 1000 rpm for 5 min,
the supernatant was removed and cells were resuspended in
complete ESA medium, containing 80% BRL-conditioned medi-
um (see below) but no additional cytokines (Petitte and Yang,
1994). The cells were seeded onto a STO feeder layer in
gelatinised 48 well plates (one blastoderm per well) and left for
2 days. Half of the medium was replaced on each subsequent
day. After 6–7 days, the cells were passaged onto fresh STO
feeder layers in 48well plates (1:2 dilution). This was continued
for about 4–5 weeks, when cells with the typical morphology of
ES cells (rounded, birefringent or phase-bright) appear and
other blastodermal cells die. Cultures were allowed to become
confluent and passaged into two wells, repeating this proce-
dure until enough cells were obtained to freeze and/or perform
experiments. Passaging was done by very brief trypsinization
(0.05% trypsin in Ca2+/Mg2+-free PBS) or by washing the cells
with PBS only. STO feeder cells were seeded at a density of
104 cells/cm2.
Buffalo Rat Liver (BRL) cell conditioned medium was
prepared by culturing BRL-3A cells (ATCC) to confluence in
150 mm tissue culture plates in 10% fetal calf serum (FCS)
(Pan) in DMEM (Gibco) with 2 mM glutamine and then
changed to 5% FCS in Knockout DMEM (Gibco) with 2 mM
glutamine. The medium was harvested every 3 days and
stored at 4 °C or −80 °C. The medium was filtered before
use and adjusted to 15% FCS, diluted to 80% with Knockout
DMEM, supplemented with 0.1 mM β-mercaptoethanol,
1 mM sodium pyruvate, 1% MEM non essential aminoacids,
1% vitamins (Gibco), 1 mM nucleosides (Chemicon), 2 mM
glutamine and 100 U/ml penicillin/100 mg/ml streptomycin.
This medium was stored for up to 7 days.
For comparison, we also used two established chick ES cell
lines from different sources: the 9N2 cell line, obtained from
Bertrand Pain (Acloque et al., 2004; Acloque et al., 2001; Lavial
et al., 2007; Pain et al., 1996), and line 403, obtained from
Origen Therapeutics, Burlingame, CA, USA (van de Lavoir and
Mather-Love, 2006; van de Lavoir et al., 2006).
2.2. Differentiation into mesoderm
Weused amodified version of a standardmethod for osteoblast
culture and differentiation (Li et al., 2000; Orriss et al., 2007).
Chick ES cells were grown in complete ESA on STO feedersuntil confluent in gelatinised 6 well plates. They were then
trypsinised briefly and re-seeded into gelatinised 6 well plates
without feeders at 30% confluence. The next day, the medium
was replaced with DMEM supplemented with 10% FCS and 2 mM
glutamine. Cells were grown for a further 2 days with daily
medium changes, after which the medium was supplemented
with 10 mM β-glycerophosphate and 100 μg/ml ascorbic acid.
The medium was changed daily for 7 days, after which cells
were passaged (1:2), and the medium was changed daily for a
further 7 days. The medium was then (day 14) further sup-
plemented with 0.1 μM dexamethasone and the cells were
passaged. On day 21 the cells were passaged (1:2 ratio) and the
medium was changed every 2 days thereafter, as the growth
rate starts to slow down.
Cells continued to be passaged around once perweek (1:2 or
1:3 ratio). Fromweek 10, passaging was stopped and cells were
grown to confluence. Nodules began to appear after week 10.
Bone differentiation was assessed using alkaline phosphatase
(from weeks 3–4) or Alizarin Red and Sirius Red (at week 12)
staining methods as described below.
2.3. Differentiation into endoderm
We modified a method designed for human ES cells (D'Amour
et al., 2005; D'Amour et al., 2006) (summarised in Table 1).
Chick ES cells were grown in complete ESA in gelatinised 24 well
plates with no feeder layer and at 30% confluence and grown for
2 days as described above. On day 3, the medium was changed
to DMEM supplementedwith 1% FCS, 2 mM glutamine, 25 ng/ml
Wnt3a (R&D), and 100 ng/ml Activin A (R&D). This was replaced
with the same medium on the following day. On days 5 and 6,
this medium was replaced with DMEM supplemented with 1%
FCS, 2 mM glutamine and 100 ng/ml Activin A only. On day 7,
the medium was replaced with a different combination of
factors: DMEM containing 2% FCS, 2 mM glutamine, 50 ng/ml
FGF10 (R&D) and 0.25 μM cyclopamine (Sigma). The cells were
maintained in this for 4 days, with one medium change, after
which the cells were passaged (1:5). The next day, the medium
was changed for DMEM supplemented with 2 mM glutamine,
2 μM retinoic acid (Sigma), 0.25 μM cyclopamine, 50 ng/ml
FGF10, and 1% B27 (Gibco). Cells were cultured for another
5 days with two medium changes and then fixed in PFA for
assessment of endoderm markers (see below).
2.4. Differentiation into neuroectoderm
The method used was developed based on two protocols
designed for mouse ES cells (Wichterle et al., 2009; Ying
et al., 2003). Poly-D-lysine-coated coverslips were made by
mixing 25 ml 0.1 mg/ml poly-D-lysine (Sigma) in sterile
water to coverslips and kept overnight, covered with
clingfilm and rocked at 20 °C. Coverslips were washed 6
times with water over 3 days, after which they were air
dried and stored dessicated (K.R. Jessen and R. Mirsky,
personal communication).
Chick ES cells were grown in complete ESA on STO
feeders until confluent in gelatinised 6 well plates as described
above. They were then trypsinised briefly and re-seeded onto
poly-D-lysine-coated coverslips without feeder cells, at 30%
confluence. The next day, ESA was withdrawn and replaced
with DMEM supplemented with 10% FCS and 2 mM glutamine.
Table 1 Summary of protocols for differentiation of chick ES cells into endoderm (A) and neuroectodermal derivatives (B). The tables summarise the treatments to which the cells
are subjected on each day of culture. For details of medium composition see Sections 2.3 and 2.4, respectively.
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23Methods for chick ES cell differentiationThe following day, this medium was withdrawn and replaced
with ADFNK (high serum): 22 ml Neurobasal medium
(Invitrogen), 22 ml Knockout DMEM, 5 ml (10%) FCS, 500 μl
penicillin/streptomycin, 500 μl glutamine (final 2 mM) and
400 μl diluted β-mercaptoethanol (Specialty Media/ Millipore).
The next day, all-trans retinoic acid (Sigma; 2 μM final
concentration) in ADFNK medium (high serum) was added.
This medium was replenished on day 5. On day 7, cells were
incubated in 100 ng/ml FGF8b (R and D), 5 ng/ml GDNF (R and
D) and 400 ng/ml Shh (R and D) in ADFNK (low serum): 23.5 ml
Neurobasal medium, 23.5 ml Knockout DMEM, 250 μl FCS
(0.5%), 500 μl penicillin/streptomycin, 500 μl glutamine,
400 μl diluted β-mercaptoethanol, 500 μl N2 (Invitrogen) and
500 μl B27 (Invitrogen) and this replenished after 2 days. On day
11, all growth factors were withdrawn from the medium and
cells were incubated in ADFNK (low serum) until days 18–20
with medium changes every 2 days. Cells were fixed in PFA for
15 min at 4 °C for assessment of expression of neural markers
(see below).2.5. Differentiation markers
To stain for alkaline phosphatase, cells were washed gently
with PBS (Ca2+/Mg2+ free) and fixed in 4% paraformalde-
hyde (PFA) at 4 °C then incubated at room temperature
with 5-bromo-4-chloro-3-indolyl-phosphate (Roche) and
4-nitro blue tetrazolium chloride (Roche) until blue colour
appeared (about 30 min). To stain for Ca2+ deposits in
bone, cells were fixed in PFA and stained with 1% aqueous
Alizarin Red (Sigma), rinsed in 50% ethanol and air dried.
Sirius Red was used to assess the presence of collagen
fibres in these cultures; cultures were fixed in Bouin's and
stained in Sirius Red (Biocolour Ltd UK) as described (Orriss
et al., 2007).
In situ hybridisation for Pdx1 (gift from A. Grapin-Botton),
Sox17 (Kimura et al., 2006) and PouV (chickOct3/4 orthologue)
(Lavial et al., 2007) was done using a modification of an in situ
protocol described for chick embryo whole-mounts (Stern,
1998). Cells were fixed in fresh PFA containing 2 mM EGTA (pH
7.4) at 4 °C overnight, then placed in methanol at −20 °C
overnight and then rehydrated through 75%, 50% and 25%
methanol in PTW (PBS with 0.1% Tween), followed by two short
PTW washes. Cells were then post-fixed with PFA containing
0.1% glutaraldehyde for 30 min, washed with PTW twice, then
once with hybridisation mix (Stern, 1998). Fresh hybridisation
mix was added to the cells, and the plates were wrapped and
sealed, then placed into an airtight humidified box and
incubated at 70 °C for 2 h. The solution was then replaced
with RNA probe in hybridisation mix, and the plate was
incubated at 70 °C in the humidified container overnight.
Cells were then washed three times, for 30 min at 70 °C with
hybridisation buffer followed by one 20 min wash with a
pre-warmed 1:1 hybridisation mix:TBST. After 3 TBST washes
at 20 °C (1 h each), non-specific antigenic sites were blocked
with 0.1% BSA (Sigma) and 5% goat serum in TBST for 1–2 h at
20 °C. Anti-Digoxigenin AP antibody (Roche) was diluted into
this solution at 1:5000 and the cells were incubated overnight
at 4 °C. Cells were then washed three times (1 h) in TBST at
4 °C followed by 2 washes in NTMT. The alkaline phosphatase
reaction was developed by incubation at 20 °C in NBT and BCIP
(Roche) in TBST as described (Stern, 1998). When the colourwas fully developed, the cells were washed in TBST then fixed
and stored in 4% PFA.
Neural differentiation was assessed with antibodies A2B11
(recognising transitin, a chick homologue of Nestin) (Fischer
and Omar, 2005) and 3A10 (neurofilament-associated protein)
(primary antibodies were obtained from the Developmental
Studies Hybridoma Bank, maintained by the Department of
Pharmacology and Molecular Sciences, The John Hopkins
University School of Medicine, Baltimore, MD 21205, under
contract N01-HD-2-3144 from NICHD), and used at 1:40 dilution
in PBS with 0.1% Triton-X100 and 1% BSA at 4 °C. After washing
in PBS, Alexa Fluor-594 coupled goat anti-rat IgM (for A2B11)
and Alexa Fluor-488 labelled donkey anti-mouse IgG (for 3A10)
(Molecular Probes) were used at 1:500 dilution in the same
blocking buffer for 1 hour at 20 °C. Cells were washed and
mounted in Vectashield (Vecta), which contains DAPI, and
examined by immunofluorescence.
3. Results
3.1. Establishment of cell lines
We have followed the protocol originally described by Petitte
and Yang (1994), withminormodifications: omitting the initial
trypsin dissociation of blastoderms and pooling of blastoderms
(we plated a single blastoderm in eachwell of a 48-well plate).
In addition, when the medium surrounding the cells appears
very acidic, we have diluted the ESA medium by a further 20%
with DMEM with additives as described in Materials and
methods. Under these conditions cells maintain the pH more
stably and appear to grow more robustly. We find that this
method generates cultures of self-renewing cells with indis-
tinguishable morphologies and other characteristics previous-
ly described by the Petitte (Petitte and Yang, 1994), Etches
(Pain et al., 1996; van de Lavoir and Mather-Love, 2006; van
de Lavoir et al., 2006) and Pain (Acloque et al., 2004; Acloque
et al., 2001; Lavial et al., 2007) laboratories. All experiments
in the present study were carried out in parallel using a cell
line from the Etches laboratory (Origen Therapeutics, cell line
403), one provided by Pain (9N2) and one generated by our
own laboratory (cell line 30). All three cell lines behaved
similarly when subjected to the differentiation protocols
described here. For consistency, however, all figures illustrate
the results obtained with line 9N2.
3.2. Differentiation into bone (mesoderm)
The cultures adopt a typical osteogenic morphology be-
tween the second and third weeks (Fig. 1A and B). Alkaline
phosphatase is expressed in growing ES cells but is also a
marker of osteoblasts (Li et al., 2000; Orriss et al., 2007).
Chick ES cells express this enzyme (Pain et al., 1996); in this
differentiation protocol, expression is lost by 2 weeks (not
shown) and starts to reappear at around 3–4 weeks (Fig. 1C).
At the same time, large whorls and other geometric patterns
can be seen in the cultures (Fig. 1B and D). Several further
weeks of culture are required before the appearance of large
patterns of collagen fibres stained by Sirius Red (Fig. 1D) and
bony mineral deposition revealed by Alizarin Red (Fig. 1E). By
this time, large areas of the culture dish display complex bone
nodules visible with the naked eye (for example see Fig. 1E).
24 S. Boast, C.D. SternTo test for the presence of cartilage,we stained these cultures
with Alcian Blue using standard methods (Orriss et al., 2007);
none was detected (not shown). These findings demonstrateFigure 1 Differentiation of chick ES cells intomesoderm. (A and B) P
(B) into the differentiation protocol described. Note that the cells c
phosphatase positive cells seen at weeks 5–6 into the protocol. The
positive. (D) Sirius Red staining (for Collagen) 12 weeks into different
stained with Alizarin Red, revealing a large bony structure containingthat the protocol described can efficiently generate large
areas of bone differentiation which are even accompanied by
characteristic mineral deposition.hase contrast micrographs of 9N2 ES cells 2 weeks (A) and 3 weeks
hange morphology between these two time points. (C) Alkaline
re is heterogeneity, but a substantial proportion of the cells are
iation. (E) Phase contrast montage micrograph of a bone deposit
Calcium deposits. The scale bar in (E) is 0.5 mm.
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There are very few specific markers that recognise all chick
endoderm cells. Sox17, often used as a marker in amphibians
and zebrafish as well as mammalian cells, is not expressed by
all endoderm cells, even in the embryo (Kimura et al., 2006)
which precludes its use as a marker. We therefore used Pdx1, a
specific pancreatic and duodenal cell marker that is exclusively
expressed in cells of endodermal origin (Ahlgren et al., 1996;
Kim et al., 1997; Larsson et al., 1996) in conjunction with the
characteristic flat morphology of endodermal cells in culture.
Growing ES cells express PouV (Oct3/4 homologue) but not
Pdx1 (Lavial et al., 2007) (Fig. 2A and B). After the protocolFigure 2 Differentiation of chick ES cells into endoderm. (A and B) In
cells express the Oct3/4 homologue PouV (A) but not the endodermalm
cells express Pdx1 RNA. (C) is a bright field view and (D) shows the same
Pdx1, some as compact clumps and somemore adherent to the substra
bright field view and (F) is the corresponding phase contrast image. No
cells, characteristic of endoderm, in (D) and (F).described in Section 2.3, we observe large areas of Pdx1mRNA
expression (Fig. 2C and D), whereas PouV is completely absent
(Fig. 2E and F). The cells have lost the rounded morphology
typical of ES cells (Fig. 2A and B) and instead look flattened,
forming a continuous monolayer of cells that adhere to each
other; this corresponds to the “pavement epithelium” mor-
phology characteristic of endodermal cells (Fig. 2D and F).3.4. Differentiation into neuroectodermal cell types
The protocol reported in Section 2.4 efficiently generates
cells that extend an intricate network of neurites, expressingthe growing phase (at the start of the differentiation protocol), ES
arker Pdx1. (C and D) After the differentiation protocol described,
field in phase contrast. Note that there are many cells expressing
te. (E and F) In contrast, these cells no longer express PouV. (E) is a
te the pavement epithelium-like morphology of the differentiated
Figure 3 Differentiation of ES cells into neuroectoderm. Immu-
nofluorescence of chick ES cells induced to differentiate into
neural lineages. (A) A network of neurites covers the culture dish,
revealed by immunofluorescence with 3A10 antibody, recognising
neurofilament-associated protein (NAPA) (green), the nuclei
counter-stained with DAPI (blue). (B) Double-staining with 3A10
(green) and transitin (chick nestin-like marker for glial and
neuronal precursor cells) (red) reveals that some cells co-express
the twomarkers and others are positive for one or the other. These
transitin-positive cells include some with glial (fibroblastic-like)
morphology and others that more closely resemble neurons.
Nuclear DAPI counterstain shown in blue. (C) In cultures stained
for transitin (red) and DAPI (blue), some transitin-positive cells
with polarised cytoplasmic extensions can be seen to be dividing,
consistent with them being neuronal precursors.
26 S. Boast, C.D. Sternthe specific neurofilament-associated antigen 3A10 (Storey
et al., 1992) (Fig. 3A and B) as well as Transitin (Fig. 3B and C),
reported to be the chick homologue of Nestin (Fischer andOmar, 2005). Some cells can be seen to express both proteins,
whereas others express either one or the other (Fig. 3B).
There appear to be more Transitin-expressing cells (probably
corresponding to neuronal precursors and glial cells) than
mature neurons (Fig. 3B). Consistent with this, we observe
that the cultures contain Transitin-expressing cells undergoing
cell division (e.g. Fig. 3C). These findings demonstrate that
the protocol described in Section 2.4 is an efficient method for
generating neuronal precursors and mature neurons from
chick embryonic stem cells in monolayer culture.4. Discussion and conclusions
Most current research on embryonic stem cells, their
capacity to self-renew and to give rise to multiple cell
types (pluripotency), uses cells obtained from mammalian
embryos, especially mouse and human (for reviews see:
Nichols and Smith (2009) and Rossant (2008)). Loss of
pluripotency appears to be a gradual process. When
obtained from the inner cell mass of very early (blastocyst)
embryos, the cells can differentiate into all somatic cell
types as well as to germ cells, but not to extraembryonic
(trophectoderm) derivatives. Cells obtained from slightly
later stages (egg cylinder stages) can still generate somatic
derivatives corresponding to all embryonic germ layers but
they have lost the ability for gametogenesis. To distinguish the
early and later cells, the former are usually referred to as true
embryonic stem cells (ES cells) and the latter as epiblast-
derived, or Epi-Stem cells (Nichols and Smith, 2009; Rossant,
2008).
Very little comparable work has been done for non-
mammalian systems. To date, aside from mammals, it has
only been possible to generate pluripotent, permanent cell
lines derived from very early (pre-gastrulation stage)
embryos from avian species, especially the chick. It is
likely that this is due to a number of properties character-
istic of amniote species. Anamniotes (fishes, amphibians
and invertebrates) generally undergo very rapid initial
divisions following fertilisation, where the cell cycle
consists only of S- and M-phases and does not involve
significant transcription until about 10 divisions have taken
place (the “mid-blastula” transition, when the zygotic
genome is first activated). In these embryos, cell fate is
therefore initially determined by differential inheritance of
maternal RNAs and proteins, which probably precludes the
establishment of truly pluripotent cells (reviewed in (Stern
and Downs, 2012)). It is therefore likely that true ES cells first
made their appearance at the time of the anamniote-to-
amniote transition during evolution.
To understand which properties may be mammalian-
specific, and which may be ancestral, it is desirable to
derive cells from avian and reptilian systems and compare
these with their mammalian counterparts. To date, only
chick embryonic stem cells have been studied to any
significant extent (Lavial and Pain, 2010; Petitte et al.,
2004; van de Lavoir et al., 2006). However, their degree of
pluripotency has only been assessed either by construction
of chimaeras in vivo or via the production of multicellular
embryonic bodies (EB), and no method was available for
directing differentiation into specific cell types in monolayer
cultures comparable to the most commonly used mammalian
27Methods for chick ES cell differentiationexperimental systems. Here we describe three simple and
robust protocols for generating cells from each of the three
germ layers from chick blastodermal cells: mesoderm
(bone), endoderm and ectoderm (neuroectodermal deriva-
tives: neurons and transitin-positive neuronal precursors/
glia).
The results confirm that these chick blastodermal cells,
obtained from embryos at stage X (Eyal-Giladi and Kochav,
1976), are indeed pluripotent. However it appears from
studies in chimaeras that these cells can only contribute to
somatic lineages, but not to the germ line (Lavial and Pain,
2010; Petitte et al., 2004). Therefore chick ES cells derived
from early blastoderms may be more akin to mouse Epi-Stem
cells and to human ES cells than to true murine ES cells
(Nichols and Smith, 2009; Rossant, 2008). Nevertheless, our
current study as well as previous experiments demonstrating
differentiation into different cell types from EB cultures,
and contribution to many somatic lineages in chimaeras,
demonstrate that they are truly pluripotent and that they
can contribute to derivatives of all three germ layers. These
methods should therefore provide a useful resource for the
study of the factors that direct cells down these various
pathways.
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